Virometix offers co-development partnerships for vaccines against pneumococcal diseases, cervical cancer, respiratory viruses, and other selected infectious or chronic human diseases. Virometix is also offering SVLP technology partnering and R&D collaborations in other application areas, including monoclonal antibody development, formulation of biologics and peptides and drug delivery.
For partnering enquiries, please contact us at [email protected].
Grants & Awards
Our awards include the following
